Using TMS to Understand Neural Processes of Social Motivation
Launched by AUBURN UNIVERSITY · Feb 15, 2024
Trial Information
Current as of August 29, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how a technique called transcranial magnetic stimulation (TMS) can help researchers understand the brain processes involved in social motivation. The study focuses on adults who struggle with social situations, have symptoms of depression, or experience social anxiety. By using TMS, the researchers hope to learn more about the neural pathways in the brain that influence social behaviors.
To participate, you need to be between 25 and 50 years old and live in the Auburn/Opelika area. You should have a diagnosis of either Major Depressive Disorder or Social Anxiety Disorder, and show signs of avoiding social interactions. The study requires four visits over approximately a month, each lasting between 1.5 to 3 hours. During these visits, you'll answer surveys, participate in interviews and computer tasks, and undergo MRI scans along with TMS sessions. Please note that there are certain health conditions that may prevent you from participating, such as recent changes in medication or a history of seizures. Overall, this study aims to deepen our understanding of how our brains work when it comes to social interactions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A diagnosis of Major Depressive Disorder OR a diagnosis of Social Anxiety Disorder (assessed/confirmed at screening visit).
- • Scoring above clinical threshold on a measure of social avoidant behavior (assessed/confirmed at screening visit).
- Exclusion Criteria:
- • Unstable medication regimen (i.e., changes in medication or dosage in past 3 months).
- • Current or lifetime diagnosis of Bipolar Disorder.
- • A diagnosis of substance use disorder within past 12 months.
- • A diagnosis of psychotic-spectrum disorder such as Schizophrenia.
- • Pregnancy or probable pregnancy.
- • Medical illness or medical treatment that would preclude or inhibit study participation.
- • Neurological disorder or prior neurosurgical procedure.
- • History of seizures or head trauma.
- • Metal implants or objects within body (e.g., pacemaker).
About Auburn University
Auburn University is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a commitment to interdisciplinary collaboration, the university leverages its diverse expertise in health sciences, engineering, and social sciences to conduct rigorous research that addresses pressing healthcare challenges. Auburn University’s Clinical Trials Office ensures adherence to ethical standards and regulatory compliance, facilitating high-quality research that contributes to the scientific community and enhances patient care. Through its robust infrastructure and support services, Auburn University is poised to make significant contributions to clinical research and public health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported